Cystitis - 142 Studies Found Completed : Urinary Biomarkers Characteristic to Interstitial Cystitis : Interstitial Cystitis : 2009-09-02 Withdrawn : Effect of Intravesical Lidocaine on Urodynamic and Symptomatic Parameters of Interstitial Cystitis : Interstitial Cystitis : 2009-01-14 : Procedure: Urodynamic study A Terminated : Effectiveness and Safety Study of Pentosan Polysulfate Sodium for the Treatment of Interstitial Cystitis : Interstitial Cystitis : 2004-07-07 : Drug: Pentosan polysulfate sodium 100 mg Completed : Assessment of UTI Symptoms and Quality of Life According to Antibiotics Treatment in Acute Uncomplicated Cystitis : Acute Cystitis : 2012-06-27 : Drug: Ciprobay Ciprobay (250mg, bid, oral) Completed : Intravesical Botulinum Toxin A Injections in Treatment of Interstitial Cystitis Refractory to Conventional Treatment : Interstitial Cystitis : 2013-10-22 : Drug: Botulinum toxin A Patien Terminated : A Study To Investigate Tanezumab In Patients With Interstitial Cystitis/ Painful Bladder Syndrome : Cystitis, Interstitial : 2009-10-20 : Biological: Tanezumab 1 mg dos Completed : Events Preceding Interstitial Cystitis (EPIC) : Cystitis, Interstitial : 2005-11-03 Completed : Efficacy of Combined Intravesical Therapy With Hyaluronic Acid and Chondroitin Sulphate in the Treatment of Recurrent Cystitis Refractory to Escherichia Coli Extract : Recurrent Cystitis : 2015-02-12 : Drug: IALURIL IALURIL Intravesical instillation with cystoscope ( 1st month: once a week, 2nd~5th month: Completed : A Pilot Clinical Investigation of the Efficacy and Safety of Uracyst® Versus Placebo in Patients With Interstitial Cystitis/Painful Bladder Syndrome. : Interstitial Cystitis : 2007-09-07 : Device: placebo bladder instil Completed : Efficacy Study of Adalimumab to Treat Interstitial Cystitis : Interstitial Cystitis : 2011-02-14 : Drug: Adalimumab 80 mg loading <<< Previous | Next >>>
